Results 51 to 60 of about 608,159 (405)

Knowledge and Attitudes Towards Clinical Trial Participation in Oman: A cross-sectional study

Sultan Qaboos University Medical Journal, 2018
Objectives: Clinical trials are prospective studies on human subjects designed to answer various clinical questions. However, only a limited number of clinical trials have been conducted in Oman.
Hussain Al-Lawati, Khalid Al-Baimani, Mahra Al-Zadjali, Nasra Al-Obaidani, Ziyana Al-Kiyumi, Murtadha K. Al-Khabori   +5 more
doaj   +1 more source

Management of Aphthous Ulceration with Topical Quercetin: A Randomized Clinical Trial [PDF]

The Journal of Contemporary Dental Practice, 2010
Abstract Aim Recurrent aphthous ulceration is the most commonly known oral mucosal disease. Quercetin is a useful therapeutic agent for the treatment of colitis and gastric ulcer. The objective of this study was to determine the effect of topical application of quercetin in the treatment of minor aphthous ulcers.
Mohamed Abd El-Moneam Ibrahem, Ahmed Abd El-Meguid Mostafa Hamdy   +1 more
openaire   +2 more sources

Clinical Trials in Portugal: Past and Future. Position Paper from the Colleges of Clinical Pharmacology and Pharmaceutical Medicine

Acta Médica Portuguesa
N/a.
Filipa Borges-Carneiro, Miguel Torre Souto, Isabel Silva, Paula Leão Moreira, Paula Ferraz de Oliveira, Diogo José Lopes, Luís Figueira, Marta Reina-Couto, Luís Cunha-Miranda, Diogo Ponces Bento, Fernando Magro   +10 more
doaj   +1 more source

Decision aids for randomised controlled trials : a qualitative exploration of stakeholders' views [PDF]

, 2014
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Campbell, Marion K, Gillies, Kate, Skea, Zoë C   +2 more
core   +1 more source

Novel trial designs: Master protocol trials

Perspectives in Clinical Research
Conventional trial designs are resource and time-intensive. To accelerate the process of testing new interventions, we now have several novel research trial designs.
Priya Ranganathan, Vishal Deo, C. S. Pramesh, Mahesh P. Parmar   +3 more
doaj   +1 more source

Asking new questions with old data: The Centralized Open-Access Rehabilitation database for Stroke (SCOAR).

Frontiers in Neurology, 2016
Background: This paper introduces a tool for streamlining data integration in rehabilitation science, the Centralized Open-Access Rehabilitation database for Stroke (SCOAR), which allows researchers to quickly visualize relationships among variables ...
Keith Lohse, Sydney Y Schaefer, Sydney Y Schaefer, Adam Raikes, Lara Boyd, Catherine E Lang   +5 more
doaj   +1 more source

Topical Tacrolimus for High-risk Corneal Transplantation: A randomized, clinical trial

BMC Ophthalmology, 2022
Abstract Immunological rejection after high-risk penetrating keratoplasty (PKP) remains a major problem. We investigated the efficacy and safety of topical tacrolimus (TAC) in these patients. This randomised clinical trial performed at a tertiary referral hospital included eyes of patients with a history of PKP, graft rejection, atopic ...
Shimazaki, J, Tomida, D, Yagi-Yaguchi, Y, Satake, Y, Yamaguchi, T   +4 more
openaire   +4 more sources

Limits to the Evaluation of the Accuracy of Continuous Glucose Monitoring Systems by Clinical Trials

Biosensors, 2018
Systems for continuous glucose monitoring (CGM) are evolving quickly, and the data obtained are expected to become the basis for clinical decisions for many patients with diabetes in the near future.
P. Schrangl, F. Reiterer, L. Heinemann, G. Freckmann, L. del Re   +4 more
semanticscholar   +1 more source

Barriers and facilitators to healthcare professional behaviour change in clinical trials using the Theoretical Domains Framework: a case study of a trial of individualized temperature-reduced haemodialysis

Trials, 2017
BackgroundImplementing the treatment arm of a clinical trial often requires changes to healthcare practices. Barriers to such changes may undermine the delivery of the treatment making it more likely that the trial will demonstrate no treatment effect ...
J. Presseau, Brittany Mutsaers, Ahmed A. Al-Jaishi, J. Squires, C. McIntyre, A. Garg, M. Sood, J. Grimshaw   +7 more
semanticscholar   +1 more source

Targeting mTOR in Pancreatic Ductal Adenocarcinoma

Frontiers in Oncology, 2016
Treatment options for advanced pancreatic ductal adenocarcinoma (PDAC) are limited, however, new therapies targeting specific tumor-related molecular characteristics may help certain patient cohorts. Emerging preclinical data has shown that inhibition of
Sentia eIriana, Shahzad eAhmed, Jun eGong, Jun eGong, Alagappan Anand Annamalai, Richard eTuli, Andrew Eugene Hendifar   +6 more
doaj   +1 more source